Grifols to Acquire Transfusion Diagnostics Business of Novartis for $1,675M

Grifols (NASDAQ: GRFS ), a global healthcare company and leading producer of plasma therapies, and Novartis (NYSE: NVS ), today announced that they have signed a definitive agreement whereby Grifols will acquire the transfusion diagnostics unit of Novartis for a total amount of US$1,675 million (€1,240 million). The